Tai-An Lin - 02 Oct 2023 Form 4 Insider Report for SpringWorks Therapeutics, Inc. (SWTX)

Role: Chief Scientific Officer
Signature: /s/ Francis I. Perier, Jr. as Attorney-in Fact
Issuer symbol: SWTX
Transactions as of: 02 Oct 2023
Net transactions value: $0
Form type: 4
Filing time: 04 Oct 2023, 16:18:52 UTC
Previous filing: 15 Sep 2023
Next filing: 08 Jan 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SWTX	Common Stock	Award		+24,000			24,000	02 Oct 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SWTX	Stock Option (Right to Buy)	Award	$0	+75,000		$0.000000	75,000	02 Oct 2023	Common Stock	75,000	$22.80	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This transaction represents a grant of restricted stock units ("RSUs"). The RSUs shall vest as follows: thirty three percent (33%) to vest on October 2, 2024, another thirty three percent (33%) to vest on October 2, 2025 and the remaining thirty four percent (34%) to vest on October 2, 2026, such that the restricted stock awards are fully vested on October 2, 2026, subject to continued service to the Issuer by the Reporting Person.
F2	Twenty-five percent (25%) of this option shall vest and become exercisable on October 2, 2024, with the remaining seventy-five percent (75%) to vest in thirty-six (36) equal monthly installments thereafter, subject to continued service to the Issuer by the Reporting Person.

Content

This transaction represents a grant of restricted stock units ("RSUs"). The RSUs shall vest as follows: thirty three percent (33%) to vest on October 2, 2024, another thirty three percent (33%) to vest on October 2, 2025 and the remaining thirty four percent (34%) to vest on October 2, 2026, such that the restricted stock awards are fully vested on October 2, 2026, subject to continued service to the Issuer by the Reporting Person.

Twenty-five percent (25%) of this option shall vest and become exercisable on October 2, 2024, with the remaining seventy-five percent (75%) to vest in thirty-six (36) equal monthly installments thereafter, subject to continued service to the Issuer by the Reporting Person.